Search details
1.
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.
Cancer
; 128(18): 3383-3391, 2022 09 15.
Article
in English
| MEDLINE | ID: mdl-35792683
2.
An updated review of the treatment landscape for advanced gastrointestinal stromal tumors.
Cancer
; 127(13): 2187-2195, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-33974733
3.
Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma.
Cancer
; 127(8): 1311-1317, 2021 04 15.
Article
in English
| MEDLINE | ID: mdl-33296083
4.
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
Cancer
; 127(16): 2934-2942, 2021 08 15.
Article
in English
| MEDLINE | ID: mdl-33910263
5.
Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.
Cancer
; 125(24): 4435-4441, 2019 Dec 15.
Article
in English
| MEDLINE | ID: mdl-31503332
6.
Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma.
Oncologist
; 24(1): 110-116, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30082492
7.
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.
BMC Cancer
; 18(1): 913, 2018 Sep 24.
Article
in English
| MEDLINE | ID: mdl-30249211
8.
Clinical trial enrollment of adolescents and young adults with sarcoma.
Cancer
; 123(18): 3434-3440, 2017 Sep 15.
Article
in English
| MEDLINE | ID: mdl-28493547
9.
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
Cancer
; 123(1): 90-97, 2017 Jan 01.
Article
in English
| MEDLINE | ID: mdl-27696380
10.
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 387(10028): 1629-37, 2016 Apr 16.
Article
in English
| MEDLINE | ID: mdl-26874885
11.
Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults.
Oncologist
; 22(10): 1271-1277, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28710342
12.
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.
Gynecol Oncol
; 146(3): 531-537, 2017 09.
Article
in English
| MEDLINE | ID: mdl-28651804
13.
The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
Curr Oncol Rep
; 19(12): 78, 2017 Oct 13.
Article
in English
| MEDLINE | ID: mdl-29030741
14.
Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?
Curr Treat Options Oncol
; 18(6): 34, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28534249
15.
Chemotherapy for soft tissue sarcoma.
Cancer
; 122(19): 2952-60, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27434055
16.
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma.
Cancer
; 122(6): 868-74, 2016 Mar 15.
Article
in English
| MEDLINE | ID: mdl-26710211
17.
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas.
Mol Cancer Ther
; 2024 Apr 02.
Article
in English
| MEDLINE | ID: mdl-38561019
18.
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma.
Clin Cancer Res
; 29(7): 1200-1208, 2023 04 03.
Article
in English
| MEDLINE | ID: mdl-36302173
19.
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).
Clin Cancer Res
; 29(9): 1708-1718, 2023 05 01.
Article
in English
| MEDLINE | ID: mdl-37058010
20.
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts.
Cancer Treat Rev
; 112: 102491, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36502615